Time spent outside of the hospital, CKD progression, and mortality: a prospective cohort study
- PMID: 33386581
- DOI: 10.1007/s11255-020-02749-8
Time spent outside of the hospital, CKD progression, and mortality: a prospective cohort study
Abstract
Purpose: Home time-being out of any healthcare facility-has been proposed as a patient-centered outcome. This novel measure has not been investigated in patients with chronic kidney disease (CKD). The aim of this study is to determine whether there was an association between home time and occurrence of end-stage renal disease (ESRD) or all-cause mortality during 1 year of follow-up.
Methods: We assembled a prospective cohort of patients with CKD not requiring dialysis at the Nephrology Center of First Affiliated Hospital of Jiaxing University between May 2014 and April 2017 and followed up for 1 year. Home time was calculated as the number of days spent out of a hospital, rehabilitation facility, or skilled nursing facility. Outcomes included progression to ESRD and all-cause mortality.
Results: Among 943 patients, 882 (93.5%) had complete follow-up through 1 year. Mean home time was 246.9 ± 126.7 days. In regression analysis, several patient characteristics were associated with significantly reduced home time, including diabetes mellitus, cardiovascular disease, and albuminuria. Home time was strongly correlated with time-to-event endpoints of ESRD (τ=0.324) and all-cause mortality (τ=0.785).
Conclusions: Home time is significantly reduced for patients with CKD not requiring dialysis and is highly correlated with traditional time-to-event endpoints. Home time serves as a novel, easily calculated, patient-centered outcome that may reflect effect of interventions on future CKD research.
Keywords: Chronic kidney disease; Home time; Mortality; Patient-centered outcome.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V. part of Springer Nature.
Similar articles
-
Home-Time After Discharge Among Patients Hospitalized With Heart Failure.J Am Coll Cardiol. 2018 Jun 12;71(23):2643-2652. doi: 10.1016/j.jacc.2018.03.517. J Am Coll Cardiol. 2018. PMID: 29880124 Free PMC article.
-
Risk of ESRD and death in patients with CKD not referred to a nephrologist: a 7-year prospective study.Clin J Am Soc Nephrol. 2014 Sep 5;9(9):1586-93. doi: 10.2215/CJN.10481013. Epub 2014 Jul 29. Clin J Am Soc Nephrol. 2014. PMID: 25074838 Free PMC article.
-
Association of Chronic Kidney Disease With In-Hospital Outcomes of Transcatheter Aortic Valve Replacement.JACC Cardiovasc Interv. 2017 Oct 23;10(20):2050-2060. doi: 10.1016/j.jcin.2017.07.044. JACC Cardiovasc Interv. 2017. PMID: 29050621
-
Long-term mortality and risk factors for development of end-stage renal disease in critically ill patients with and without chronic kidney disease.Crit Care. 2015 Nov 3;19:383. doi: 10.1186/s13054-015-1101-8. Crit Care. 2015. PMID: 26526622 Free PMC article. Clinical Trial.
-
Pulmonary Hypertension, Mortality, and Cardiovascular Disease in CKD and ESRD Patients: A Systematic Review and Meta-analysis.Am J Kidney Dis. 2018 Jul;72(1):75-83. doi: 10.1053/j.ajkd.2017.11.018. Epub 2018 Feb 9. Am J Kidney Dis. 2018. PMID: 29429751
References
-
- Wang S, Chen R, Liu Q, Shu Z, Zhan S, Li L (2015) Prevalence, awareness and treatment of chronic kidney disease among middle-aged and elderly: the china health and retirement longitudinal study. Nephrology 20(7):474–484. https://doi.org/10.1111/nep.12449 - DOI - PubMed
-
- Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, Chen M, He Q, Liao Y, Yu X, Chen N, Zhang JE, Hu Z, Liu F, Hong D, Ma L, Liu H, Zhou X, Chen J, Pan L, Chen W, Wang W, Li X, Wang H (2012) Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 379(9818):815–822. https://doi.org/10.1016/S0140-6736(12)60033-6 - DOI - PubMed
-
- Huang YP, Zheng T, Zhang DH, Chen LY, Mao PJ (2016) Community-based study on elderly CKD subjects and the associated risk factors. Ren Fail 38(10):1672–1676. https://doi.org/10.1080/0886022X.2016.1229987 - DOI - PubMed
-
- Fukuma S, Kurita N, Fukagawa M, Akizawa T, Fukuhara S (2013) Impact of cinacalcet introduction on MBD management: the MBD-5D study in Japan. Kidney Int Suppl 3(5):436–441. https://doi.org/10.1038/kisup.2013.91 - DOI
-
- Wu HY, Huang JW, Lin HJ, Liao WC, Peng YS, Hung KY, Wu KD, Tu YK, Chien KL (2013) Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis. BMJ 347:f6008. https://doi.org/10.1136/bmj.f6008 - DOI - PubMed - PMC
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous